Ame Company For Medical Supplies
TADAWUL:9527.SR
118 (SAR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 24.212 | 9.039 | 0 | 43.403 | 43.403 | 26.419 | 23.321 | 7.008 | 28.417 | 27.697 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 24.212 | 9.039 | 43.403 | 43.403 | 43.403 | 26.419 | 23.321 | 7.008 | 28.417 | 27.697 |
| Net Receivables
| 120.894 | 110.188 | 0 | 89.807 | 86.544 | 93.3 | 79.506 | 87.154 | 69.834 | 64.083 |
| Inventory
| 76.358 | 51.173 | 0 | 50.357 | 44.945 | 39.579 | 45.709 | 31.863 | 28.988 | 21.451 |
| Other Current Assets
| 0.521 | 23.215 | 0 | 0.384 | 9.059 | 8.45 | 3.275 | 13.132 | 3.621 | 3.374 |
| Total Current Assets
| 221.984 | 193.616 | 43.403 | 183.951 | 183.951 | 167.748 | 151.811 | 139.157 | 130.86 | 116.606 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 3.368 | 3.853 | 0 | 4.74 | 4.74 | 5.174 | 2.199 | 2.589 | 2.238 | 0.676 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 1.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 2.605 | 0 | 0 | 1.529 | 0 | 2.038 | 0.353 | 1.29 | 0.79 | 1.409 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 4.377 | -43.403 | 0 | 1.529 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 7.425 | 8.23 | -43.403 | 6.269 | 6.269 | 7.212 | 2.552 | 3.879 | 3.029 | 2.085 |
| Total Assets
| 229.409 | 201.846 | 0 | 190.219 | 190.219 | 174.96 | 154.362 | 143.037 | 133.888 | 118.691 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 4.541 | 0.597 | 0 | 0.511 | 0.511 | 0 | 5.391 | 0.4 | 0.247 | 0.38 |
| Short Term Debt
| 1.085 | 0.979 | 0 | 1.202 | 1.202 | 0.577 | 0.394 | 0.398 | 0.382 | 4.77 |
| Tax Payables
| 0 | 5.667 | 0 | 7.552 | 0 | 5.643 | 5.391 | 3.863 | 3.881 | 2.25 |
| Deferred Revenue
| 2.187 | 0 | 0 | 1.267 | 0 | 1.2 | 0.983 | 35.572 | 1.504 | 2.175 |
| Other Current Liabilities
| 51.06 | 44.076 | 0 | 41.63 | 50.449 | 40.518 | 25.268 | 31.924 | 25.894 | 22.509 |
| Total Current Liabilities
| 58.873 | 51.32 | 0 | 52.162 | 52.162 | 47.938 | 37.429 | 38.466 | 31.907 | 32.084 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 0.542 | 0.869 | 0 | 1.396 | 1.396 | 2.143 | 0.708 | 0.772 | 1.122 | 0.035 |
| Deferred Revenue Non-Current
| 0.4 | 0.136 | 0 | 0.243 | 0 | 0.318 | 0.267 | 0.081 | 0.37 | 0.311 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 10.765 | 9.759 | -127.169 | 9.249 | 9.492 | 9.005 | 8.609 | 7.176 | 7.075 | 4.191 |
| Total Non-Current Liabilities
| 11.707 | 10.764 | -127.169 | 10.888 | 10.888 | 11.466 | 9.584 | 8.029 | 8.566 | 4.538 |
| Total Liabilities
| 70.58 | 62.084 | -127.169 | 63.05 | 63.05 | 59.404 | 47.013 | 46.496 | 40.474 | 36.621 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 70 | 70 | 0 | 70 | 70 | 70 | 70 | 70 | 70 | 70 |
| Retained Earnings
| 83.789 | 64.722 | 0 | 52.129 | 57.169 | 40.516 | 32.309 | 24.169 | 21.042 | 11.82 |
| Accumulated Other Comprehensive Income/Loss
| 5.041 | 0 | 127.169 | 5.041 | 0 | 5.041 | 5.041 | 2.372 | 2.372 | 0.25 |
| Other Total Stockholders Equity
| 0 | 5.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 158.829 | 139.762 | 127.169 | 127.169 | 127.169 | 115.557 | 107.35 | 96.541 | 93.414 | 82.07 |
| Total Equity
| 158.829 | 139.762 | 127.169 | 127.169 | 127.169 | 115.557 | 107.35 | 96.541 | 93.414 | 82.07 |
| Total Liabilities & Shareholders Equity
| 229.409 | 201.846 | 0 | 190.219 | 190.219 | 174.96 | 154.362 | 143.037 | 133.888 | 118.691 |